| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/16/2005 | CN1580054A Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity |
| 02/16/2005 | CN1579546A Isulin solid granular, its preparation method and its use in preparing medicine for treating diabetes |
| 02/16/2005 | CN1579535A Medicinal composition for auxiliary treatment of asthenia healthy qi and its quality control method |
| 02/16/2005 | CN1579532A Method for extracting medicinal component of Yongchongcao |
| 02/16/2005 | CN1579530A Ready made traditional Chinese medicine for treating diabetes and its preparation method |
| 02/16/2005 | CN1579500A Medicine for treating diabetes |
| 02/16/2005 | CN1579483A Medicinal preparation of traditional Chinese medicine for treating diabetes and its production method |
| 02/16/2005 | CN1579463A Compound cape-jasmine salted-fermented beans total extract and its preparation and use |
| 02/16/2005 | CN1579458A Danshenhong medicated liquor for treating thoracic obstruction and preparation method |
| 02/16/2005 | CN1579445A Effective-component extract of Foliun-Mori and its preparation method |
| 02/16/2005 | CN1579424A Prevention of disease induced by taking high phenylalanine and treatment there for |
| 02/16/2005 | CN1579423A Compound comprised royal jelly and nutrient composition comprising said compound |
| 02/16/2005 | CN1579387A Extraction of protopine from plant, and its manufacture of medicinal preparation and use |
| 02/16/2005 | CN1579376A Rhizoma-curcumae-longae element-soft cap sule and its preparation method |
| 02/16/2005 | CN1189472C Use of otigosaccharide |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189202C Compound ginkgo capsule |
| 02/16/2005 | CN1189185C Woodfrog egg oil capsule and its production process |
| 02/16/2005 | CN1189177C Use of chitin oligosaccharide sulphate and/or chitin sulfate for preparing medicine for diabetes |
| 02/16/2005 | CN1189176C Astragalus root methyl-glycoside composition and preparation method |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/16/2005 | CN1189167C Compound amino acid injecta and its prepn process |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855826 1,3-butadienes, perhydrobutadienes, ethylenes and ethanes as amino acid derivatives; hypotensive agents; antidiabetic agents and (pre)eclampsia treatments |
| 02/15/2005 | US6855732 Containing one or more optionally hydrogenated substituted styryl groups; especially 3-(3,5-dimethoxyphenyl)-2-(p-(p-(2,2-bis(methoxycarbonyl)-viny l)phenoxy)phenyl)acrylic acid |
| 02/15/2005 | US6855727 Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/14/2005 | CA2477359A1 Pyruvate enriched onion extract |
| 02/10/2005 | WO2005012570A1 METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10 |
| 02/10/2005 | WO2005012346A1 Long lasting insulin derivatives and methods thereof |
| 02/10/2005 | WO2005012321A1 Novel compounds |
| 02/10/2005 | WO2005012307A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/10/2005 | WO2005012295A1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same |
| 02/10/2005 | WO2005012284A1 4,5-DIHYDRONAPHTHO[1,2-b]THIOPHENE DERIVATIVE |
| 02/10/2005 | WO2005012282A1 Novel 2-thiosubstituted benzothiophene derivatives, method for production of and pharmaceutical compositions comprising the same |
| 02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
| 02/10/2005 | WO2005012272A1 Benzoxazepine compound |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005012245A1 Novel heteroaryl derivative |
| 02/10/2005 | WO2005012244A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | WO2005012221A1 Diphenyl ether compound, process for producing the same, and use |
| 02/10/2005 | WO2005011812A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibithors |
| 02/10/2005 | WO2005011706A1 2-METHYLENE-19-NOR-20(S)-25-METHYL-1α-HYDROXYCALCIFEROL AND ITS USES |
| 02/10/2005 | WO2005011693A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011685A1 Aryl dicarboxamides |
| 02/10/2005 | WO2005011680A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 02/10/2005 | WO2005011677A1 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases |
| 02/10/2005 | WO2005011672A1 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 02/10/2005 | WO2005011670A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011657A2 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011655A2 Pyridazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011654A2 Pyridyl derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011653A2 Pyridazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011581A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | WO2004112701A3 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | US20050034179 Transgenic animal cell which express tumor necrosis factor receptor for use in identifying agents for treatment of diabetes and inflammatory bowel disease |
| 02/10/2005 | US20050033066 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/10/2005 | US20050033057 Thiazoline acid derivatives |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050033052 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032898 Oral amino acid composition |
| 02/10/2005 | US20050032890 Aniline-derived ligands for the thyroid receptor |
| 02/10/2005 | US20050032884 Eluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 02/10/2005 | US20050032878 Peroxisome proliferator activated compound of fenofibrate, ciprofibrate, clofibrate, gemifibrozil and/or bezafibrate; and pravastatin, simvastatin, lovastatin, fluvastatin, atorvastatin, cerivastatin, pravastatin and/or mixtures; and polyglycolized glyceride; dissolving, bioavailability |
| 02/10/2005 | US20050032874 Indole derivatives |
| 02/10/2005 | US20050032865 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 02/10/2005 | US20050032854 Administering 2-ethoxy-1-[[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid or a salt as a hypotensive or an antidiabetic agent; impaired glucose tolerance |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032843 Dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole in combination with a second active substance selected from D1, D2, D3, and D4 receptor agonists, anorectics, lipase inhibitors and sympathomimetics; for treating overweight or obesity or type 2 diabetes |
| 02/10/2005 | US20050032828 E. g., 4-[3-Isopropyl-3-(2-mercapto-benzothiazol-6-yl)-ureido]-piperidine-1-carboxylic acid benzyl ester; metabolic diseases; management/treatment glucose/fatty acid pathway; cardiovascular disorders; congestive heart failure; angina pectoris; antidiabetic agent, anticarcinogenic agents; obesity |
| 02/10/2005 | US20050032825 rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis |
| 02/10/2005 | US20050032823 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032812 Administering a dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole or talipexol; for treating overweight or obesity or type 2 diabetes |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
| 02/10/2005 | US20050032804 Dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; inhibitor of dipeptidyl peptidase-IV, useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus |
| 02/10/2005 | US20050032796 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032787 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 02/10/2005 | US20050032779 enzyme inhibitors such as 2-[4-(4-Dimethylaminophenyl)piperazin-1-yl]4,5-dihydroimidazo[4,5,1-ij]quinolin-6-one, used for treating or preventing disorders in which poly/ADP-ribose/ polymerase is involved |
| 02/10/2005 | US20050032776 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032768 pentsaaacycle manganese complexes used as mimetics for oxidoreductase enzymes, for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects |
| 02/10/2005 | US20050032761 Lipid profile modulation |
| 02/10/2005 | US20050032754 the 2-position is substituted, the steric configuration at the 20-position is native or epimerized, and the double bond at the 5-position is in E configuration; calcium metabolism regulating agent; does not cause hypercalcemia during long-term use |
| 02/10/2005 | US20050032746 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 02/10/2005 | US20050032686 administering to a manimal a therapeutically effective amount of ES-62 ( a glycoprotein) to treat an inflammatory disease: arthritis and chronic obstructive pulmonary disease |
| 02/10/2005 | US20050032207 Method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032064 Method and device for identifying substances capable of modulating adipocyte differentiation |